Surmeier DJ - Search Results

1

Calcium, Bioenergetics, and Parkinson's Disease.

Zampese E, Surmeier DJ. Zampese E, et al. Among authors: surmeier dj. Cells. 2020 Sep 8;9(9):2045. doi: 10.3390/cells9092045. Cells. 2020. PMID: 32911641 Free PMC article. Review.

2

Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models.

Day M, Wang Z, Ding J, An X, Ingham CA, Shering AF, Wokosin D, Ilijic E, Sun Z, Sampson AR, Mugnaini E, Deutch AY, Sesack SR, Arbuthnott GW, Surmeier DJ. Day M, et al. Among authors: surmeier dj. Nat Neurosci. 2006 Feb;9(2):251-9. doi: 10.1038/nn1632. Epub 2006 Jan 15. Nat Neurosci. 2006. PMID: 16415865

3

'Rejuvenation' protects neurons in mouse models of Parkinson's disease.

Chan CS, Guzman JN, Ilijic E, Mercer JN, Rick C, Tkatch T, Meredith GE, Surmeier DJ. Chan CS, et al. Among authors: surmeier dj. Nature. 2007 Jun 28;447(7148):1081-6. doi: 10.1038/nature05865. Epub 2007 Jun 10. Nature. 2007. PMID: 17558391

4

Calcium, ageing, and neuronal vulnerability in Parkinson's disease.

Surmeier DJ. Surmeier DJ. Lancet Neurol. 2007 Oct;6(10):933-8. doi: 10.1016/S1474-4422(07)70246-6. Lancet Neurol. 2007. PMID: 17884683 Review.

5

Calcium homeostasis, selective vulnerability and Parkinson's disease.

Chan CS, Gertler TS, Surmeier DJ. Chan CS, et al. Among authors: surmeier dj. Trends Neurosci. 2009 May;32(5):249-56. doi: 10.1016/j.tins.2009.01.006. Epub 2009 Mar 21. Trends Neurosci. 2009. PMID: 19307031 Free PMC article. Review.

6

Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease.

Surmeier DJ, Guzman JN, Sanchez-Padilla J. Surmeier DJ, et al. Cell Calcium. 2010 Feb;47(2):175-82. doi: 10.1016/j.ceca.2009.12.003. Epub 2010 Jan 6. Cell Calcium. 2010. PMID: 20053445 Free PMC article. Review.

7

A molecular basis for the increased vulnerability of substantia nigra dopamine neurons in aging and Parkinson's disease.

Chan CS, Gertler TS, Surmeier DJ. Chan CS, et al. Among authors: surmeier dj. Mov Disord. 2010;25 Suppl 1:S63-70. doi: 10.1002/mds.22801. Mov Disord. 2010. PMID: 20187241

8

What causes the death of dopaminergic neurons in Parkinson's disease?

Surmeier DJ, Guzman JN, Sanchez-Padilla J, Goldberg JA. Surmeier DJ, et al. Prog Brain Res. 2010;183:59-77. doi: 10.1016/S0079-6123(10)83004-3. Prog Brain Res. 2010. PMID: 20696315

9

The origins of oxidant stress in Parkinson's disease and therapeutic strategies.

Surmeier DJ, Guzman JN, Sanchez-Padilla J, Goldberg JA. Surmeier DJ, et al. Antioxid Redox Signal. 2011 Apr 1;14(7):1289-301. doi: 10.1089/ars.2010.3521. Epub 2010 Dec 15. Antioxid Redox Signal. 2011. PMID: 20712409 Free PMC article. Review.

10

Tolerability of isradipine in early Parkinson's disease: a pilot dose escalation study.

Simuni T, Borushko E, Avram MJ, Miskevics S, Martel A, Zadikoff C, Videnovic A, Weaver FM, Williams K, Surmeier DJ. Simuni T, et al. Among authors: surmeier dj. Mov Disord. 2010 Dec 15;25(16):2863-6. doi: 10.1002/mds.23308. Mov Disord. 2010. PMID: 20818667 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

281 results

Search Page

Filters